Idorsia Ltd. (IDRSF)
5.38
0.00 (0.00%)
USD |
OTCM |
Oct 16, 16:00
Idorsia Cash from Operations (Annual) : -203.32M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -203.32M |
| December 31, 2024 | -420.40M |
| December 31, 2023 | -700.27M |
| December 31, 2022 | -899.53M |
| December 31, 2021 | -645.21M |
| Date | Value |
|---|---|
| December 31, 2020 | -388.52M |
| December 31, 2019 | -464.93M |
| December 31, 2018 | -360.51M |
| December 31, 2017 | 97.02M |
| December 31, 2016 | -267.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Basilea Pharmaceutica AG | 74.76M |
| Santhera Pharmaceuticals Holding AG | -41.86M |
| BeOne Medicines Ltd. | 1.131B |
| AC Immune SA | -83.40M |
| CRISPR Therapeutics AG | -345.01M |